{"schema_version":"secwatch.filing_event.v1","accession":"0001013762-23-003650","form_type":"8-K","ticker":"ALBT","cik":"0001630212","company_name":"Avalon GloboCare Corp.","filed_at":"2023-10-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.841633+00:00","generated_at":"2026-06-10T00:02:37.224245+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Avalon GloboCare shareholders elect directors and approve all proposals at 2023 annual meeting","bullets":["All 7 director nominees elected, including Wenzhao Lu (5.53M for) and David Jin (5.55M for).","Ratified Marcum LLP as auditor with 7.22M for, 13.8K against, 32.6K abstain.","Approved Preferred Share Issuance Proposal (5.52M for, 21.5K against) for conversion of Series A/B Preferred.","Approved Note Share Issuance Proposal related to May/July 2023 securities purchase agreements (5.52M for).","Approved Amended 2020 Stock Incentive Plan (5.45M for) and advisory vote on NEO compensation (5.52M for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001013762-23-003650","json":"https://secwatch.observer/filing/0001013762-23-003650.json","markdown":"https://secwatch.observer/filing/0001013762-23-003650.md","text":"https://secwatch.observer/filing/0001013762-23-003650.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/ea186676-8k_avalon.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T00:02:37.224245+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"013ea638a5cec1c13bfa523be80f4759ff2eaa68","claim":"Avalon GloboCare Corp. shareholders approved Advisory vote on compensation of named executive officers at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,517,897 32,782 6,770 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"0702cd5205e40bb235f12e15a3909ec7f30ca2cf","claim":"Avalon GloboCare Corp. shareholders approved Approve the Note Share Issuance Proposal (potential issuance of shares pursuant to May and July securities purchase agreements, notes, and warrants) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,830 20,888 17,731 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"76b20986578bf99484dcb549c441c820dcaa09e4","claim":"Avalon GloboCare Corp. shareholders approved Election of seven directors at the 2023-10-12 meeting.","evidence_excerpt":"FOR WITHHELD BROKER NON-VOTES Wenzhao Lu 5,528,621 28,828 1,707,228 David Jin, MD, PhD 5,550,026 7,423 1,707,228 Steven A. Sanders 5,503,532 53,917 1,707,228 Lourdes Felix 5,525,718 31,731 1,707,228 Wilbert J. Tauzin II 5,530,783 26,666 1,707,228 William B. Stilley, III 5,502,958 54,491 1,707,228 Tevi Troy 5,503,496 53,953 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"89a408c4c7b29c5ef38f8823cb1e4f62d1dd7dfc","claim":"Avalon GloboCare Corp. shareholders approved Advisory vote on frequency of future advisory votes on executive compensation at the 2023-10-12 meeting.","evidence_excerpt":"ONE YEAR TWO YEARS THREE YEARS ABSTAIN BROKER NON-VOTES 5,529,740 21,533 3,545 2,631 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"a17dacdf72f037bac23b733612c91ea48037e5e3","claim":"Avalon GloboCare Corp. shareholders approved Approve the Amended and Restated 2020 Stock Incentive Plan (Plan Proposal) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,451,360 87,665 18,424 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"c14976c2e44c4516f5ee2eda95797dbbdcf57c57","claim":"Avalon GloboCare Corp. shareholders approved Ratify the appointment of Marcum LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 7,218,220 13,827 32,630 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"},{"claim_id":"e025c94ff2974390caed13109b6ec3acb03076d9","claim":"Avalon GloboCare Corp. shareholders approved Approve the Preferred Share Issuance Proposal (potential issuance of shares upon conversion of Series A and Series B Convertible Preferred Stock in connection with acquisition of Laboratory Services MSO, LLC) at the 2023-10-12 meeting.","evidence_excerpt":"FOR AGAINST ABSTAIN BROKER NON-VOTES 5,518,824 21,487 17,138 1,707,228","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630212/000101376223003650/0001013762-23-003650-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-10-12"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}